Background and ObjectivesLeigh
syndrome is an important manifestation of childhood-onset primary
mitochondrial disease. Panel sequencing and whole exome sequencing are
cost-effective for diagnosing mitochondrial diseases; however, more than
half of mitochondrial disease cases remain genetically undiagnosed.
This study aimed to demonstrate that combining whole genome sequencing
(WGS) and RNA sequencing (RNA-seq) analyses can identify disease-causing
variants that would otherwise be missed.MethodsWe
performed WGS and RNA-seq on a patient with Leigh syndrome. Chromosomal
phasing using Sanger sequencing of parental and patient blood samples
was conducted to confirm compound heterozygous variants. RNA-seq data
were analyzed for splicing abnormalities. Overexpression studies of
wild-type NDUFA3 in patient-derived fibroblasts were performed to assess restoration of mitochondrial function.ResultsWe discovered compound heterozygous intronic variants (c.86-16_86-15del in intron2 and c.164-362G>A in intron3) of the NDUFA3 gene. RNA-seq data analysis revealed intron retention and exonization in NDUFA3.
Exonization was related to a variant involving the mobile element Alu
that resulted in complex abnormal splicing events. Overexpression of
wild-type NDUFA3 restored mitochondrial dysfunction in patient-derived fibroblasts, confirming NDUFA3 as a Leigh syndrome causative gene.DiscussionThis
study highlights the importance of combining WGS and RNA-seq and
provides new insights into detecting abnormalities in deep intronic
regions, particularly those involving mobile elements, such as Alu. This
approach can play a crucial role in identifying genetic variations and
elucidating transcriptional control mechanisms that are not readily
achieved by conventional methods, especially in the context of mobile
element-induced complexities.